Close

Mr Sam Willcocks

Assistant Professor

United Kingdom

I am a Research Fellow who is dual-qualified as a Molecular Biologist and an Innate Immunologist, with a particular interest in host-pathogen interactions. I have extensive experience in Biosafety Level Three pathogens, and seek to develop novel and host-directed alternatives to current antimicrobials. I am a committed and collaborative academic who secures significant funding in pursuit of basic and translational research towards novel therapeutics.

Affiliations

Department of Infection Biology
Faculty of Infectious and Tropical Diseases

Centres

TB Centre
Antimicrobial Resistance Centre

Teaching

* Supervisor of three previous PhD students
* Advisory board member for one current PhD student
* Supervisor of seven previous MSc Summer laboratory project students
* Mentor to one MSc student per year
* Lecturer in up to six subjects each year including AMR and Burkholderia pathogenesis
* Mentor for Fleming Fellow (Zimbabwe)
* Distance learning tutor for six years
* Registered Assessor, University of London Examiners Board
* Teaching of practical classes for MSc Immunology since 2010
* Attended module 1, PGCILT

Research

Antimicrobial Resistance
Drug Discovery
Innate Immunity
Tuberculosis
Immunomodulation
Research Area
Bacteria
Chemotherapy
Drug discovery and development
Drug resistance
Immunisation
Innate immunity
Medicines
Public health
Vaccines
Bacteriology
Biochemistry
Bioinformatics
Cell biology
Genetics
Genomics
Immunology
Immunopathology
Microbiology
Molecular biology
Pharmacology
Disease and Health Conditions
Neglected Tropical Diseases (NTDs)
Tropical diseases
Tuberculosis
Infectious diseases
Respiratory diseases
Country
Thailand
United Kingdom
Region
World

Selected Publications

Revisiting aminocoumarins for the treatment of melioidosis.
WILLCOCKS, SJ; Cia, F; FRANCISCO, AF; WREN, BW;
2020
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
Virulence of the emerging pathogen, Burkholderia pseudomallei, depends upon the O-linked oligosaccharyltransferase, PglL.
WILLCOCKS, SJ; Denman, C; Cia, F; McCarthy, E; CUCCUI, J; WREN, BW;
2020
Future Microbiol
Understanding<i>Campylobacter coli</i>isolates from the Vietnamese meat production network; a pilot study
Lehri, B; Navoly, G; Corser, A; Nashar, F; WILLCOCKS, S; Ngoc, PT; WREN, B; Huong, LQ; STABLER, R;
2023
bioRxiv
Genomic and Phenotypic Characterisation of Campylobacter Coli Isolates from Vietnamese Farms and Retail
Lehri, B; Georgina, N; Corser, A; Nashar, F; WILLCOCKS, S; Ngoc, PT; Wren, B; Huong, LQ; Stabler, RA;
2023
Elsevier BV
Synthesis, biological evaluation and computational studies of pyrazole derivatives as Mycobacterium tuberculosis CYP121A1 inhibitors.
Alshabani, LA; Kumar, A; WILLCOCKS, SJ; Srithiran, G; Bhakta, S; Estrada, DF; Simons, C;
2022
RSC Medicinal Chemistry
Defining the Genes Required for Survival of Mycobacterium bovis in the Bovine Host Offers Novel Insights into the Genetic Basis of Survival of Pathogenic Mycobacteria.
Gibson, AJ; Stiens, J; PASSMORE, IJ; Faulkner, V; Miculob, J; WILLCOCKS, S; Coad, M; Berg, S; Werling, D; WREN, BW; Nobeli, I; Villarreal-Ramos, B; Kendall, SL;
2022
mBio
Strain Specific Variations in Acinetobacter baumannii Complement Sensitivity.
Kamuyu, G; Ercoli, G; Ramos-Sevillano, E; WILLCOCKS, S; Kewcharoenwong, C; Kiratisin, P; Taylor, PW; WREN, BW; Lertmemongkolchai, G; STABLER, RA; Brown, JS;
2022
Frontiers in immunology
Defining the genes required for survival of Mycobacterium bovis in the bovine host offers novel insights into the genetic basis of survival of pathogenic mycobacteria
Gibson, AJ; Stiens, J; PASSMORE, IJ; Faulkner, V; Miculob, J; WILLCOCKS, S; Coad, M; Berg, S; Werling, D; WREN, BW; Nobeli, I; Villarreal-Ramos, B; Kendall, SL;
2022
Zenodo
Engineering a suite of E. coli strains for enhanced expression of bacterial polysaccharides and glycoconjugate vaccines.
KAY, EJ; MAURI, M; WILLCOCKS, SJ; SCOTT, TA; CUCCUI, J; WREN, BW;
2022
MICROBIAL CELL FACTORIES
See more information